<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d215" origId="Felbamate"><sentence id="DrugDDI.d215.s0" origId="s0" text="The drug interaction data described in this section were obtained from controlled clinical trials and studies involving otherwise healthy adults with epilepsy."/><sentence id="DrugDDI.d215.s1" origId="s1" text="Use in Conjunction with Other Antiepileptic Drugs: The addition of Felbatol? to antiepileptic drugs (AEDs) affects the steady-state plasma concentrations of AEDs."><entity id="DrugDDI.d215.s1.e0" origId="s1.p12" charOffset="30-49" type="drug" text="Antiepileptic Drugs"/><entity id="DrugDDI.d215.s1.e1" origId="s1.p16" charOffset="80-99" type="drug" text="antiepileptic drugs"/><pair id="DrugDDI.d215.s1.p0" e1="DrugDDI.d215.s1.e0" e2="DrugDDI.d215.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s2" origId="s2" text="The net effect of these interactions is summarized in the following table: AED AED Felbatol?"/><sentence id="DrugDDI.d215.s3" origId="s3" text="Coadministered Concentration Concentration"/><sentence id="DrugDDI.d215.s4" origId="s4" text="Phenytoin ? ?"><entity id="DrugDDI.d215.s4.e0" origId="s4.p30" charOffset="0-9" type="drug" text="Phenytoin"/></sentence><sentence id="DrugDDI.d215.s5" origId="s5" text="Valproate ? ?**"><entity id="DrugDDI.d215.s5.e0" origId="s5.p31" charOffset="0-9" type="drug" text="Valproate"/></sentence><sentence id="DrugDDI.d215.s6" origId="s6" text="Carbamazepine (CBZ) ? ?"><entity id="DrugDDI.d215.s6.e0" origId="s6.p32" charOffset="0-13" type="drug" text="Carbamazepine"/></sentence><sentence id="DrugDDI.d215.s7" origId="s7" text="*CBZ epoxide ? ?"/><sentence id="DrugDDI.d215.s8" origId="s8" text="Phenobarbital ? ?"><entity id="DrugDDI.d215.s8.e0" origId="s8.p38" charOffset="0-13" type="drug" text="Phenobarbital"/></sentence><sentence id="DrugDDI.d215.s9" origId="s9" text="*Not administered, but an active metabolite of carbamazepine."><entity id="DrugDDI.d215.s9.e0" origId="s9.p44" charOffset="26-43" type="drug" text="active metabolite"/><entity id="DrugDDI.d215.s9.e1" origId="s9.p45" charOffset="47-60" type="drug" text="carbamazepine"/><pair id="DrugDDI.d215.s9.p0" e1="DrugDDI.d215.s9.e0" e2="DrugDDI.d215.s9.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s10" origId="s10" text="**No significant effect."/><sentence id="DrugDDI.d215.s11" origId="s11" text="Specific Effects of Felbatol? on Other Antiepileptic Drugs Phenytoin: Felbatol? causes an increase in steady-state phenytoin plasma concentrations."><entity id="DrugDDI.d215.s11.e0" origId="s11.p49" charOffset="39-58" type="drug" text="Antiepileptic Drugs"/><entity id="DrugDDI.d215.s11.e1" origId="s11.p52" charOffset="115-124" type="drug" text="phenytoin"/><pair id="DrugDDI.d215.s11.p0" e1="DrugDDI.d215.s11.e0" e2="DrugDDI.d215.s11.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s12" origId="s12" text="In 10 otherwise healthy subjects with epilepsy ingesting phenytoin, the steadystate trough (Cmin) phenytoin plasma concentration was 17?5 micrograms/mL."><entity id="DrugDDI.d215.s12.e0" origId="s12.p54" charOffset="57-66" type="drug" text="phenytoin"/><entity id="DrugDDI.d215.s12.e1" origId="s12.p59" charOffset="98-107" type="drug" text="phenytoin"/><pair id="DrugDDI.d215.s12.p0" e1="DrugDDI.d215.s12.e0" e2="DrugDDI.d215.s12.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s13" origId="s13" text="The steady-state Cmin increased to 21?5 micrograms/mL when 1200 mg/day of felbamate was coadministered."><entity id="DrugDDI.d215.s13.e0" origId="s13.p70" charOffset="74-83" type="drug" text="felbamate"/></sentence><sentence id="DrugDDI.d215.s14" origId="s14" text="Increasing the felbamate dose to 1800 mg/day in six of these subjects increased the steady-state phenytoin Cmin to 25?7 micrograms/mL."><entity id="DrugDDI.d215.s14.e0" origId="s14.p80" charOffset="97-106" type="drug" text="phenytoin"/></sentence><sentence id="DrugDDI.d215.s15" origId="s15" text="In order to maintain phenytoin levels, limit adverse experiences, and achieve the felbamate dose of 3600 mg/day, a phenytoin dose reduction of approximately 40% was necessary for eight of these 10 subjects."/><sentence id="DrugDDI.d215.s16" origId="s16" text="In a controlled clinical trial, a 20% reduction of the phenytoin dose at the initiation of Felbatol? therapy resulted in phenytoin levels comparable to those prior to Felbatol? administration."/><sentence id="DrugDDI.d215.s17" origId="s17" text="Carbamazepine: Felbatol? causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine epoxide plasma concentration."><entity id="DrugDDI.d215.s17.e0" origId="s17.p107" charOffset="0-13" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d215.s17.e1" origId="s17.p110" charOffset="63-76" type="drug" text="carbamazepine"/><entity id="DrugDDI.d215.s17.e2" origId="s17.p113" charOffset="135-156" type="drug" text="carbamazepine epoxide"/><pair id="DrugDDI.d215.s17.p0" e1="DrugDDI.d215.s17.e0" e2="DrugDDI.d215.s17.e1" interaction="false"/><pair id="DrugDDI.d215.s17.p1" e1="DrugDDI.d215.s17.e0" e2="DrugDDI.d215.s17.e2" interaction="false"/><pair id="DrugDDI.d215.s17.p2" e1="DrugDDI.d215.s17.e1" e2="DrugDDI.d215.s17.e2" interaction="false"/></sentence><sentence id="DrugDDI.d215.s18" origId="s18" text="In nine otherwise healthy subjects with epilepsy ingesting carbamazepine, the steady-state trough (Cmin) carbamazepine concentration was 8?2 micrograms/mL."><entity id="DrugDDI.d215.s18.e0" origId="s18.p115" charOffset="59-72" type="drug" text="carbamazepine"/><entity id="DrugDDI.d215.s18.e1" origId="s18.p120" charOffset="105-118" type="drug" text="carbamazepine"/><pair id="DrugDDI.d215.s18.p0" e1="DrugDDI.d215.s18.e0" e2="DrugDDI.d215.s18.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s19" origId="s19" text="The carbamazepine steady-state Cmin decreased 31% to 5?1 micrograms/mL when felbamate (3000 mg/day, divided into three doses) was coadministered."><entity id="DrugDDI.d215.s19.e0" origId="s19.p124" charOffset="4-17" type="drug" text="carbamazepine"/><entity id="DrugDDI.d215.s19.e1" origId="s19.p130" charOffset="76-85" type="drug" text="felbamate"/><pair id="DrugDDI.d215.s19.p0" e1="DrugDDI.d215.s19.e0" e2="DrugDDI.d215.s19.e1" interaction="true"/></sentence><sentence id="DrugDDI.d215.s20" origId="s20" text="Carbamazepine epoxide steady-state Cmin concentrations increased 57% from 1.0?0.3 to 1.6?0.4 micrograms/mL with the addition of felbamate."><entity id="DrugDDI.d215.s20.e0" origId="s20.p139" charOffset="0-21" type="drug" text="Carbamazepine epoxide"/><entity id="DrugDDI.d215.s20.e1" origId="s20.p146" charOffset="128-137" type="drug" text="felbamate"/><pair id="DrugDDI.d215.s20.p0" e1="DrugDDI.d215.s20.e0" e2="DrugDDI.d215.s20.e1" interaction="true"/></sentence><sentence id="DrugDDI.d215.s21" origId="s21" text="In clinical trials, similar changes in carbamazepine and carbamazepine epoxide were seen."><entity id="DrugDDI.d215.s21.e0" origId="s21.p149" charOffset="39-52" type="drug" text="carbamazepine"/><entity id="DrugDDI.d215.s21.e1" origId="s21.p151" charOffset="57-78" type="drug" text="carbamazepine epoxide"/><pair id="DrugDDI.d215.s21.p0" e1="DrugDDI.d215.s21.e0" e2="DrugDDI.d215.s21.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s22" origId="s22" text="Valproate: Felbatol? causes an increase in steady-state valproate concentrations."><entity id="DrugDDI.d215.s22.e0" origId="s22.p154" charOffset="0-9" type="drug" text="Valproate"/><entity id="DrugDDI.d215.s22.e1" origId="s22.p157" charOffset="56-65" type="drug" text="valproate"/><pair id="DrugDDI.d215.s22.p0" e1="DrugDDI.d215.s22.e0" e2="DrugDDI.d215.s22.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s23" origId="s23" text="In four subjects with epilepsy ingesting valproate, the steady-state trough (Cmin) valproate plasma concentration was 63?16 micrograms/mL."><entity id="DrugDDI.d215.s23.e0" origId="s23.p159" charOffset="41-50" type="drug" text="valproate"/><entity id="DrugDDI.d215.s23.e1" origId="s23.p164" charOffset="83-92" type="drug" text="valproate"/><pair id="DrugDDI.d215.s23.p0" e1="DrugDDI.d215.s23.e0" e2="DrugDDI.d215.s23.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s24" origId="s24" text="The steady-state Cmin increased to 78?14 micrograms/mL when 1200 mg/day of felbamate was coadministered."><entity id="DrugDDI.d215.s24.e0" origId="s24.p175" charOffset="75-84" type="drug" text="felbamate"/></sentence><sentence id="DrugDDI.d215.s25" origId="s25" text="Increasing the felbamate dose to 2400 mg/day increased the steadystate valproate Cmin to 96?25 micrograms/mL."><entity id="DrugDDI.d215.s25.e0" origId="s25.p183" charOffset="71-80" type="drug" text="valproate"/></sentence><sentence id="DrugDDI.d215.s26" origId="s26" text="Corresponding values for free valproate Cmin concentrations were 7?3, 9?4, and 11?6 micrograms/mL for 0, 1200, and 2400 mg/day Felbatol?, respectively."/><sentence id="DrugDDI.d215.s27" origId="s27" text="The ratios of the AUCs of unbound valproate to the AUCs of the total valproate were 11.1 %, 13.0%, and 11.5%, with coadministration of 0, 1200, and 2400 mg/day of Felbatol?, respectively."><entity id="DrugDDI.d215.s27.e0" origId="s27.p202" charOffset="34-43" type="drug" text="valproate"/><entity id="DrugDDI.d215.s27.e1" origId="s27.p204" charOffset="69-78" type="drug" text="valproate"/><pair id="DrugDDI.d215.s27.p0" e1="DrugDDI.d215.s27.e0" e2="DrugDDI.d215.s27.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s28" origId="s28" text="This indicates that the protein binding of valproate did not change appreciably with increasing doses of Felbatol? Phenobarbital: Coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations, In 12 otherwise healthy male volunteers ingesting phenobarbital, the steady-state trough (Cmin) phenobarbital concentration was 14.2 micrograms/mL."><entity id="DrugDDI.d215.s28.e0" origId="s28.p221" charOffset="43-52" type="drug" text="valproate"/><entity id="DrugDDI.d215.s28.e1" origId="s28.p227" charOffset="115-128" type="drug" text="Phenobarbital"/><entity id="DrugDDI.d215.s28.e2" origId="s28.p230" charOffset="150-159" type="drug" text="felbamate"/><entity id="DrugDDI.d215.s28.e3" origId="s28.p231" charOffset="165-178" type="drug" text="phenobarbital"/><entity id="DrugDDI.d215.s28.e4" origId="s28.p234" charOffset="201-214" type="drug" text="phenobarbital"/><entity id="DrugDDI.d215.s28.e5" origId="s28.p237" charOffset="288-301" type="drug" text="phenobarbital"/><entity id="DrugDDI.d215.s28.e6" origId="s28.p242" charOffset="334-347" type="drug" text="phenobarbital"/><pair id="DrugDDI.d215.s28.p0" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e1" interaction="false"/><pair id="DrugDDI.d215.s28.p1" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e2" interaction="false"/><pair id="DrugDDI.d215.s28.p2" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e3" interaction="false"/><pair id="DrugDDI.d215.s28.p3" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e4" interaction="false"/><pair id="DrugDDI.d215.s28.p4" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e5" interaction="false"/><pair id="DrugDDI.d215.s28.p5" e1="DrugDDI.d215.s28.e0" e2="DrugDDI.d215.s28.e6" interaction="false"/><pair id="DrugDDI.d215.s28.p6" e1="DrugDDI.d215.s28.e1" e2="DrugDDI.d215.s28.e2" interaction="false"/><pair id="DrugDDI.d215.s28.p7" e1="DrugDDI.d215.s28.e1" e2="DrugDDI.d215.s28.e3" interaction="false"/><pair id="DrugDDI.d215.s28.p8" e1="DrugDDI.d215.s28.e1" e2="DrugDDI.d215.s28.e4" interaction="false"/><pair id="DrugDDI.d215.s28.p9" e1="DrugDDI.d215.s28.e1" e2="DrugDDI.d215.s28.e5" interaction="false"/><pair id="DrugDDI.d215.s28.p10" e1="DrugDDI.d215.s28.e1" e2="DrugDDI.d215.s28.e6" interaction="false"/><pair id="DrugDDI.d215.s28.p11" e1="DrugDDI.d215.s28.e2" e2="DrugDDI.d215.s28.e3" interaction="true"/><pair id="DrugDDI.d215.s28.p12" e1="DrugDDI.d215.s28.e2" e2="DrugDDI.d215.s28.e4" interaction="false"/><pair id="DrugDDI.d215.s28.p13" e1="DrugDDI.d215.s28.e2" e2="DrugDDI.d215.s28.e5" interaction="false"/><pair id="DrugDDI.d215.s28.p14" e1="DrugDDI.d215.s28.e2" e2="DrugDDI.d215.s28.e6" interaction="false"/><pair id="DrugDDI.d215.s28.p15" e1="DrugDDI.d215.s28.e3" e2="DrugDDI.d215.s28.e4" interaction="false"/><pair id="DrugDDI.d215.s28.p16" e1="DrugDDI.d215.s28.e3" e2="DrugDDI.d215.s28.e5" interaction="false"/><pair id="DrugDDI.d215.s28.p17" e1="DrugDDI.d215.s28.e3" e2="DrugDDI.d215.s28.e6" interaction="false"/><pair id="DrugDDI.d215.s28.p18" e1="DrugDDI.d215.s28.e4" e2="DrugDDI.d215.s28.e5" interaction="false"/><pair id="DrugDDI.d215.s28.p19" e1="DrugDDI.d215.s28.e4" e2="DrugDDI.d215.s28.e6" interaction="false"/><pair id="DrugDDI.d215.s28.p20" e1="DrugDDI.d215.s28.e5" e2="DrugDDI.d215.s28.e6" interaction="false"/></sentence><sentence id="DrugDDI.d215.s29" origId="s29" text="The steady-state Cmin concentration increased to 17.8 micrograms/mL when 2400 mg/day of felbamate was coadministered for one week."><entity id="DrugDDI.d215.s29.e0" origId="s29.p253" charOffset="88-97" type="drug" text="felbamate"/></sentence><sentence id="DrugDDI.d215.s30" origId="s30" text="Effects of Other Antiepileptic Drugs on Felbatol? Phenytoin: Phenytoin causes an approximate doubling of the clearance of Felbatol? (felbamate) at steady state and, therefore, the addition of phenytoin causes an approximate 45% decrease in the steady-state trough concentrations of Felbatol? as compared to the same dose of Felbatol? given as monotherapy."><entity id="DrugDDI.d215.s30.e0" origId="s30.p258" charOffset="17-36" type="drug" text="Antiepileptic Drugs"/><entity id="DrugDDI.d215.s30.e1" origId="s30.p259" charOffset="50-59" type="drug" text="Phenytoin"/><entity id="DrugDDI.d215.s30.e2" origId="s30.p261" charOffset="61-70" type="drug" text="Phenytoin"/><entity id="DrugDDI.d215.s30.e3" origId="s30.p267" charOffset="133-142" type="drug" text="felbamate"/><entity id="DrugDDI.d215.s30.e4" origId="s30.p275" charOffset="192-201" type="drug" text="phenytoin"/><pair id="DrugDDI.d215.s30.p0" e1="DrugDDI.d215.s30.e0" e2="DrugDDI.d215.s30.e1" interaction="false"/><pair id="DrugDDI.d215.s30.p1" e1="DrugDDI.d215.s30.e0" e2="DrugDDI.d215.s30.e2" interaction="false"/><pair id="DrugDDI.d215.s30.p2" e1="DrugDDI.d215.s30.e0" e2="DrugDDI.d215.s30.e3" interaction="false"/><pair id="DrugDDI.d215.s30.p3" e1="DrugDDI.d215.s30.e0" e2="DrugDDI.d215.s30.e4" interaction="false"/><pair id="DrugDDI.d215.s30.p4" e1="DrugDDI.d215.s30.e1" e2="DrugDDI.d215.s30.e2" interaction="false"/><pair id="DrugDDI.d215.s30.p5" e1="DrugDDI.d215.s30.e1" e2="DrugDDI.d215.s30.e3" interaction="false"/><pair id="DrugDDI.d215.s30.p6" e1="DrugDDI.d215.s30.e1" e2="DrugDDI.d215.s30.e4" interaction="false"/><pair id="DrugDDI.d215.s30.p7" e1="DrugDDI.d215.s30.e2" e2="DrugDDI.d215.s30.e3" interaction="true"/><pair id="DrugDDI.d215.s30.p8" e1="DrugDDI.d215.s30.e2" e2="DrugDDI.d215.s30.e4" interaction="false"/><pair id="DrugDDI.d215.s30.p9" e1="DrugDDI.d215.s30.e3" e2="DrugDDI.d215.s30.e4" interaction="false"/></sentence><sentence id="DrugDDI.d215.s31" origId="s31" text="Carbamazepine: Carbamazepine causes an approximate 50% increase in the clearance of Felbatol? at steady state and, therefore, the addition of carbamazepine results in an approximate 40% decrease in the steady-state trough concentrations of Felbatol? as compared to the same dose of Felbatol? given as monotherapy."><entity id="DrugDDI.d215.s31.e0" origId="s31.p284" charOffset="0-13" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d215.s31.e1" origId="s31.p286" charOffset="15-28" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d215.s31.e2" origId="s31.p297" charOffset="142-155" type="drug" text="carbamazepine"/><pair id="DrugDDI.d215.s31.p0" e1="DrugDDI.d215.s31.e0" e2="DrugDDI.d215.s31.e1" interaction="false"/><pair id="DrugDDI.d215.s31.p1" e1="DrugDDI.d215.s31.e0" e2="DrugDDI.d215.s31.e2" interaction="false"/><pair id="DrugDDI.d215.s31.p2" e1="DrugDDI.d215.s31.e1" e2="DrugDDI.d215.s31.e2" interaction="false"/></sentence><sentence id="DrugDDI.d215.s32" origId="s32" text="Valproate: Available data suggest that there is no significant effect of valproate on the clearance of Felbatol? at steady state, Therefore, the addition of valproate is not expected to cause a clinically important effect on Felbatol? (felbamate) plasma concentrations."><entity id="DrugDDI.d215.s32.e0" origId="s32.p307" charOffset="0-9" type="drug" text="Valproate"/><entity id="DrugDDI.d215.s32.e1" origId="s32.p314" charOffset="73-82" type="drug" text="valproate"/><entity id="DrugDDI.d215.s32.e2" origId="s32.p321" charOffset="157-166" type="drug" text="valproate"/><entity id="DrugDDI.d215.s32.e3" origId="s32.p327" charOffset="236-245" type="drug" text="felbamate"/><pair id="DrugDDI.d215.s32.p0" e1="DrugDDI.d215.s32.e0" e2="DrugDDI.d215.s32.e1" interaction="false"/><pair id="DrugDDI.d215.s32.p1" e1="DrugDDI.d215.s32.e0" e2="DrugDDI.d215.s32.e2" interaction="false"/><pair id="DrugDDI.d215.s32.p2" e1="DrugDDI.d215.s32.e0" e2="DrugDDI.d215.s32.e3" interaction="false"/><pair id="DrugDDI.d215.s32.p3" e1="DrugDDI.d215.s32.e1" e2="DrugDDI.d215.s32.e2" interaction="false"/><pair id="DrugDDI.d215.s32.p4" e1="DrugDDI.d215.s32.e1" e2="DrugDDI.d215.s32.e3" interaction="false"/><pair id="DrugDDI.d215.s32.p5" e1="DrugDDI.d215.s32.e2" e2="DrugDDI.d215.s32.e3" interaction="false"/></sentence><sentence id="DrugDDI.d215.s33" origId="s33" text="Phenobarbital: It appears that phenobarbital may reduce plasma felbamate concentrations."><entity id="DrugDDI.d215.s33.e0" origId="s33.p330" charOffset="0-13" type="drug" text="Phenobarbital"/><entity id="DrugDDI.d215.s33.e1" origId="s33.p334" charOffset="31-44" type="drug" text="phenobarbital"/><entity id="DrugDDI.d215.s33.e2" origId="s33.p337" charOffset="63-72" type="drug" text="felbamate"/><pair id="DrugDDI.d215.s33.p0" e1="DrugDDI.d215.s33.e0" e2="DrugDDI.d215.s33.e1" interaction="false"/><pair id="DrugDDI.d215.s33.p1" e1="DrugDDI.d215.s33.e0" e2="DrugDDI.d215.s33.e2" interaction="false"/><pair id="DrugDDI.d215.s33.p2" e1="DrugDDI.d215.s33.e1" e2="DrugDDI.d215.s33.e2" interaction="true"/></sentence><sentence id="DrugDDI.d215.s34" origId="s34" text="Steady-state plasma felbamate concentrations were found to be 29% lower than the mean concentrations of a group of newly diagnosed subjects with epilepsy also receiving 2400 mg of felbamate a day."><entity id="DrugDDI.d215.s34.e0" origId="s34.p338" charOffset="20-29" type="drug" text="felbamate"/><entity id="DrugDDI.d215.s34.e1" origId="s34.p351" charOffset="180-189" type="drug" text="felbamate"/><pair id="DrugDDI.d215.s34.p0" e1="DrugDDI.d215.s34.e0" e2="DrugDDI.d215.s34.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s35" origId="s35" text="Effects of Antacids on Felbatol? The rate and extent of absorption of a 2400 mg dose of Felbatol? as monotherapy given as tablets was not affected when coadministered with antacids."><entity id="DrugDDI.d215.s35.e0" origId="s35.p354" charOffset="11-19" type="drug" text="Antacids"/><entity id="DrugDDI.d215.s35.e1" origId="s35.p369" charOffset="172-180" type="drug" text="antacids"/><pair id="DrugDDI.d215.s35.p0" e1="DrugDDI.d215.s35.e0" e2="DrugDDI.d215.s35.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s36" origId="s36" text="Effects of Erythromycin on Felbatol? The coadministration of erythromycin (1000 mg/day) for 10 days did not alter the pharmacokinetic parameters of Cmax, Cmin, AUC, CI/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy."><entity id="DrugDDI.d215.s36.e0" origId="s36.p371" charOffset="11-23" type="drug" text="Erythromycin"/><entity id="DrugDDI.d215.s36.e1" origId="s36.p374" charOffset="61-73" type="drug" text="erythromycin"/><pair id="DrugDDI.d215.s36.p0" e1="DrugDDI.d215.s36.e0" e2="DrugDDI.d215.s36.e1" interaction="false"/></sentence><sentence id="DrugDDI.d215.s37" origId="s37" text="Effects of Felbatol? on Low-Dose Combination Oral Contraceptives A group of 24 nonsmoking, healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle (day 15) to midcycle (day 14) of two consecutive oral contraceptive cycles."><entity id="DrugDDI.d215.s37.e0" origId="s37.p400" charOffset="24-64" type="drug" text="low-dose combination oral contraceptives"/><entity id="DrugDDI.d215.s37.e1" origId="s37.p404" charOffset="141-159" type="drug" text="oral contraceptive"/><entity id="DrugDDI.d215.s37.e2" origId="s37.p406" charOffset="185-202" type="drug" text="ethinyl estradiol"/><entity id="DrugDDI.d215.s37.e3" origId="s37.p408" charOffset="213-222" type="drug" text="gestodene"/><entity id="DrugDDI.d215.s37.e4" origId="s37.p414" charOffset="269-278" type="drug" text="felbamate"/><entity id="DrugDDI.d215.s37.e5" origId="s37.p423" charOffset="342-360" type="drug" text="oral contraceptive"/><pair id="DrugDDI.d215.s37.p0" e1="DrugDDI.d215.s37.e0" e2="DrugDDI.d215.s37.e1" interaction="false"/><pair id="DrugDDI.d215.s37.p1" e1="DrugDDI.d215.s37.e0" e2="DrugDDI.d215.s37.e2" interaction="false"/><pair id="DrugDDI.d215.s37.p2" e1="DrugDDI.d215.s37.e0" e2="DrugDDI.d215.s37.e3" interaction="false"/><pair id="DrugDDI.d215.s37.p3" e1="DrugDDI.d215.s37.e0" e2="DrugDDI.d215.s37.e4" interaction="false"/><pair id="DrugDDI.d215.s37.p4" e1="DrugDDI.d215.s37.e0" e2="DrugDDI.d215.s37.e5" interaction="false"/><pair id="DrugDDI.d215.s37.p5" e1="DrugDDI.d215.s37.e1" e2="DrugDDI.d215.s37.e2" interaction="false"/><pair id="DrugDDI.d215.s37.p6" e1="DrugDDI.d215.s37.e1" e2="DrugDDI.d215.s37.e3" interaction="false"/><pair id="DrugDDI.d215.s37.p7" e1="DrugDDI.d215.s37.e1" e2="DrugDDI.d215.s37.e4" interaction="false"/><pair id="DrugDDI.d215.s37.p8" e1="DrugDDI.d215.s37.e1" e2="DrugDDI.d215.s37.e5" interaction="false"/><pair id="DrugDDI.d215.s37.p9" e1="DrugDDI.d215.s37.e2" e2="DrugDDI.d215.s37.e3" interaction="false"/><pair id="DrugDDI.d215.s37.p10" e1="DrugDDI.d215.s37.e2" e2="DrugDDI.d215.s37.e4" interaction="false"/><pair id="DrugDDI.d215.s37.p11" e1="DrugDDI.d215.s37.e2" e2="DrugDDI.d215.s37.e5" interaction="false"/><pair id="DrugDDI.d215.s37.p12" e1="DrugDDI.d215.s37.e3" e2="DrugDDI.d215.s37.e4" interaction="false"/><pair id="DrugDDI.d215.s37.p13" e1="DrugDDI.d215.s37.e3" e2="DrugDDI.d215.s37.e5" interaction="false"/><pair id="DrugDDI.d215.s37.p14" e1="DrugDDI.d215.s37.e4" e2="DrugDDI.d215.s37.e5" interaction="false"/></sentence><sentence id="DrugDDI.d215.s38" origId="s38" text="Felbamate treatment resulted in a 42% decrease in the gestodene AUC 0-24, but no clinically relevant effect was observed on the pharmacokinetic parameters of ethinyl estradiol."><entity id="DrugDDI.d215.s38.e0" origId="s38.p424" charOffset="0-9" type="drug" text="Felbamate"/><entity id="DrugDDI.d215.s38.e1" origId="s38.p427" charOffset="54-63" type="drug" text="gestodene"/><entity id="DrugDDI.d215.s38.e2" origId="s38.p433" charOffset="158-175" type="drug" text="ethinyl estradiol"/><pair id="DrugDDI.d215.s38.p0" e1="DrugDDI.d215.s38.e0" e2="DrugDDI.d215.s38.e1" interaction="true"/><pair id="DrugDDI.d215.s38.p1" e1="DrugDDI.d215.s38.e0" e2="DrugDDI.d215.s38.e2" interaction="false"/><pair id="DrugDDI.d215.s38.p2" e1="DrugDDI.d215.s38.e1" e2="DrugDDI.d215.s38.e2" interaction="false"/></sentence><sentence id="DrugDDI.d215.s39" origId="s39" text="No volunteer showed hormonal evidence of ovulation, but one volunteer reported intermenstrual bleeding during felbamate treatment."><entity id="DrugDDI.d215.s39.e0" origId="s39.p440" charOffset="110-119" type="drug" text="felbamate"/></sentence></document>